Schedule 13D ownership disclosure

IMMUNOPRECISE ANTIBODIES LTD

Security class unavailable · CUSIP: 45257F200

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,053,186
Percent of class
4.2200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001041885-23-000015
Form type
SC 13D
Filer
INGALLS & SNYDER LLC
CIK
CIK 1041885
Filed
Jul 07, 2023
Reporting period
—
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub